Identification |
Name: | 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- |
Synonyms: | BAY43-9006;N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; |
CAS: | 284461-73-0 |
Molecular Formula: | C21H16ClF3N4O3 |
Molecular Weight: | 464.82495 |
InChI: | InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) |
Molecular Structure: |
|
Properties |
Density: | 1.454 g/cm3 |
Water Solubility: | Soluble in DMSO; very poorly soluble in water |
Solubility: | Soluble in DMSO; very poorly soluble in water |
Appearance: | White to off-white solid |
Usage: | 1. Sorafenib tosylate (284461-73-0) is commonly used as a potent RAF kinase inhibitor.
2. Sorafenib tosylate (284461-73-0) is also used as antineoplastic drug. |
Safety Data |
|
|